Ignite Creation Date:
2025-12-25 @ 3:53 AM
Ignite Modification Date:
2026-01-28 @ 8:37 PM
Study NCT ID:
NCT00779402
Status:
COMPLETED
Last Update Posted:
2018-01-29
First Post:
2008-10-22
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
PROvenge Treatment and Early Cancer Treatment
Sponsor:
Dendreon
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Prostate Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | cancer | View |
| None | prostate cancer | View |
| None | prostatectomy | View |
| None | PSA | View |
| None | sipuleucel-T | View |
| None | PROVENGE | View |
| None | APC8015 | View |
| None | non-metastatic | View |
| None | nonmetastatic | View |
| None | androgen-sensitive | View |
| None | androgen sensitive | View |
| None | biochemical recurrence | View |
| None | biochemically recurrent | View |
| None | immune therapy | View |
| None | immunotherapy | View |
| None | vaccine | View |
| None | dendritic cells | View |
| None | antigen-presenting cells | View |
| None | antigen presenting cells | View |
| None | cancer vaccine | View |
| None | therapeutic vaccine | View |
| None | therapeutic cancer vaccine | View |
| None | biologic | View |
| None | booster | View |